This experiment in primary injectants confirms our results in stable GRD transgenic lines, demonstrating that NF1 functions differently in normal development and tumorigenesis of the PSNS, and the tumor suppression function of NF1 in MYCN-induced neuroblastoma is mediated through the GAP activity of the GRD domain. The gene discussed is MYCN; the disease is neuroblastoma.